Mca-PLGL-Dpa-AR-NH2

What We Offer

Mca-PLGL-Dpa-AR-NH2

Mca-PLGL-Dpa-AR-NH2

Catalog Number A18-0035
Category Fluorescent Enzyme Substrates
Molecular Formula C43H66N12O11
Molecular Weight 927.1
Catalog Number Size Price Quantity

Product Introduction

Mca-PLGL-Dpa-AR-NH2 is a fluorogenic substrate for matrix metalloproteinase-2 (MMP-2) and MMP-7. 7-methoxycoumarin-4-acetyl (Mca) is released by cleavage of Mca-PLGL-Dpa-AR-NH2 and emits the fluorescence that can be used to quantify MMP-2 and MMP-7 activity.

Chemical Information

Synonyms Matrix Metalloproteinase-2/Matrix Metalloproteinase-7 Fluorogenic Substrate; MMP-2/MMP-7 Fluorogenic Substrate; (S)-N-((6S,9S,12S,15S,21S)-1-amino-12-(aminomethyl)-6-carbamoyl-1-imino-15-isobutyl-9,23-dimethyl-8,11,14,17,20-pentaoxo-2,7,10,13,16,19-hexaazatetracosan-21-yl)-1-(2-(7-methoxy-2-oxo-2H-chromen-4-yl)acetyl)pyrrolidine-2-carboxamide
Purity ≥95%
IUPAC Name (2S)-N-[(2S)-1-[[2-[[(2S)-1-[[(2S)-3-amino-1-[[(2S)-1-[[(2S)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-4-methyl-1-oxopentan-2-yl]-1-[2-(7-methoxy-2-oxochromen-4-yl)acetyl]pyrrolidine-2-carboxamide
Canonical SMILES CC(C)CC(C(=O)NC(CN)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)N)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)CC2=CC(=O)OC3=C2C=CC(=C3)OC
InChI InChI=1S/C43H66N12O11/c1-22(2)15-29(53-42(64)32-10-8-14-55(32)35(57)17-25-18-36(58)66-33-19-26(65-6)11-12-27(25)33)39(61)49-21-34(56)51-30(16-23(3)4)40(62)54-31(20-44)41(63)50-24(5)38(60)52-28(37(45)59)9-7-13-48-43(46)47/h11-12,18-19,22-24,28-32H,7-10,13-17,20-21,44H2,1-6H3,(H2,45,59)(H,49,61)(H,50,63)(H,51,56)(H,52,60)(H,53,64)(H,54,62)(H4,46,47,48)/t24-,28-,29-,30-,31-,32-/m0/s1
InChI Key GNGRCYXAOSUGRN-KNIQQNQGSA-N
  • Product Specification
  • Application
Storage Store at -20°C

Mca-PLGL-Dpa-AR-NH2 is a specialized fluorogenic substrate designed for evaluating the proteolytic activity of matrix metalloproteinases, specifically MMP-2 and MMP-7. This substrate consists of 7-methoxycoumarin-4-acetyl (Mca) as the fluorescent moiety, and a peptide sequence connecting Mca to Dpa-AR-NH2, which is recognized and cleaved by MMP-2 and MMP-7. Upon cleavage, Mca is released, emitting fluorescence, enabling researchers to quantify the enzymatic activity involved in various pathological and physiological conditions.

One key application of Mca-PLGL-Dpa-AR-NH2 is in cancer research. MMP-2 and MMP-7 are known to play significant roles in cancer invasion and metastasis by degrading extracellular matrix components. By monitoring their activity through this substrate, researchers can assess the efficacy of potential inhibitors in anticancer therapies. This helps in developing drugs that target MMP activity, potentially reducing tumor spread and improving patient prognosis.

Another critical application is in the study of cardiovascular diseases. MMPs, including MMP-2 and MMP-7, are involved in the remodeling processes of blood vessels, which is crucial in conditions such as atherosclerosis. Utilizing Mca-PLGL-Dpa-AR-NH2 to monitor MMP activity allows for better understanding of the molecular mechanisms underlying these diseases, aiding in the development of targeted therapeutic strategies to mitigate adverse vascular remodeling.

Mca-PLGL-Dpa-AR-NH2 is also extensively used in arthritis research, specifically for understanding the pathological degradation of joint cartilage. MMPs contribute to the breakdown of collagen in cartilage, a hallmark of arthritis. By quantifying the activity of MMP-2 and MMP-7, researchers can explore the progression of arthritis and evaluate the effectiveness of anti-arthritic drugs, facilitating the discovery of more effective treatments to alleviate symptoms and prevent joint damage.

Lastly, the substrate is valuable in investigating neurological disorders. MMPs influence the neuroinflammatory processes associated with diseases such as Alzheimer’s and multiple sclerosis. By employing Mca-PLGL-Dpa-AR-NH2, scientists can analyze MMP activity in the central nervous system, providing insights into how these enzymes affect neurodegeneration and offering potential avenues for therapeutic intervention to protect against neural damage and improve neurological outcomes.

Computed Properties

XLogP3 -1.5
Hydrogen Bond Donor Count 10
Hydrogen Bond Acceptor Count 13
Rotatable Bond Count 25
Exact Mass 926.49740097 g/mol
Monoisotopic Mass 926.49740097 g/mol
Topological Polar Surface Area 364Ų
Heavy Atom Count 66
Formal Charge 0
Complexity 1820
Isotope Atom Count 0
Defined Atom Stereocenter Count 6
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1
Compound Is Canonicalized Yes
cartIcon
Inquiry Basket